Efavirenz-associated CNS disorders linked to CYP2B6 variant

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1035卷 / 1期
关键词：
Central Nervous System; Randomise Control Trial; Haas; Efavirenz; Trial Group;
D O I：
10.2165/00128415-200510350-00009
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [21] Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism
    C. Sukasem
    W. Manosuthi
    N. Koomdee
    S. Santon
    T. Jantararoungtong
    S. Prommas
    M. Chamnanphol
    A. Puangpetch
    S. Sungkanuparph
    Infection, 2014, 42 : 469 - 474
  • [22] Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6
    Cox, Philip M.
    Bumpus, Namandj N.
    CHEMMEDCHEM, 2016, 11 (23) : 2630 - 2637
  • [23] CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!
    Cook-Sather, Scott D.
    Adamson, Peter C.
    Li, Jin
    Hakonarson, Hakon
    ANESTHESIOLOGY, 2016, 125 (06) : 1085 - 1087
  • [24] Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 alleles
    Gonzalo Restrepo, Juan
    Martinez, Carmen
    Garcia-Agundez, Augusto
    Gaviria, Elmer
    Julio Laguna, Jose
    Garcia-Martin, Elena
    Agundez, Jose A. G.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (12): : 773 - 778
  • [25] Effect of CYP2B6 genotype on the plasma efavirenz exposure in an African HIV woman
    Le Dauphin, Emmanuelle
    Barrail-Tran, Aurelie
    Brunet, Anne
    Bouligand, Jerome
    Goujard, Cecile
    Taburet, Anne-Marie
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 331 - 332
  • [26] Would a CYP2B6 test help HIV patients being treated with efavirenz?
    Sukasem, Chonlaphat
    Sungkanuparph, Somnuek
    PHARMACOGENOMICS, 2013, 14 (09) : 999 - 1001
  • [27] Genetic variants of CYP2B6 decrease rate of efavirenz metabolism in vitro.
    Desta, Z
    Ward, BA
    Flockhart, DA
    Richter, T
    Klein, K
    Zanger, UM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P24 - P24
  • [28] Potent inhibition of efavirenz secondary metabolism by CYP2B6 inhibitors in vitro.
    Huh, W.
    Jones, D. R.
    Jeong, S.
    Flockhart, D. A.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S43 - S44
  • [29] Frequency of CYP2B6 Alleles in Major Iranian Ethnicities, Affecting Response to Efavirenz
    Mardi, Parham
    Tavakoli-Far, Bahareh
    Nia, Samira Sheibani
    Jazayeri, Roshanak
    Houshmand, Massoud
    GENETICS RESEARCH, 2022, 2022
  • [30] CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women
    Roehrich, Carola R.
    Droegemoeller, Britt I.
    Ikediobi, Ogechi
    van der Merwe, Lize
    Grobbelaar, Nelis
    Wright, Galen E. B.
    McGregor, Nathaniel
    Warnich, Louise
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (06) : 529 - 538
12345